- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| home:pathogenesis:successive_infection [08.22.2017] – [Harmful effects of acute infections can take decades to be realized] sallieq | home:pathogenesis:successive_infection [03.12.2020] – [Successive infection and variability in disease] sallieq | ||
|---|---|---|---|
| Line 3: | Line 3: | ||
| ====== Successive infection and variability in disease ====== | ====== Successive infection and variability in disease ====== | ||
| - | <relatedarticle> [[home: | + | <relatedarticles> [[home: |
| Chronic diseases manifest in patients and within patient populations with a high degree of variability. Some people have five chronic diseases, and others have one. Some patients experience symptoms of disease early in life while others not until they are very old. According to the Marshall Pathogenesis, | Chronic diseases manifest in patients and within patient populations with a high degree of variability. Some people have five chronic diseases, and others have one. Some patients experience symptoms of disease early in life while others not until they are very old. According to the Marshall Pathogenesis, | ||
| Line 82: | Line 82: | ||
| Folks often assume once you’re over the acute illness, that’s it, you’re back to normal and that’s the end of it. The long-term consequences are an important but relatively poorly documented, poorly studied area of foodborne illness. | Folks often assume once you’re over the acute illness, that’s it, you’re back to normal and that’s the end of it. The long-term consequences are an important but relatively poorly documented, poorly studied area of foodborne illness. | ||
| - | //**Robert Tauxe, MD**//, Centers for Disease Control and Prevention </ | + | //**Robert Tauxe, MD**//, Centers for Disease Control and Prevention |
| O’Connor and team at the Centers for Disease Control and Prevention have identified the time before and around birth as times when acute infections seem to have their most devastating impact. | O’Connor and team at the Centers for Disease Control and Prevention have identified the time before and around birth as times when acute infections seem to have their most devastating impact. | ||
home/pathogenesis/successive_infection.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.